SCHEMBL16079706

SCHEMBL16079706

O=C(O)C1CSC(c2cccc(Br)c2)N1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.60
KDM4E B2RXH2 7/20 0.60
MAPT P10636 5/20 0.58
HSD17B10 Q99714 1/20 0.58
S1PR3 Q99500 2/20 0.58
POLB P06746 2/20 0.56
PKM P14618 1/20 0.53
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
RECQL P46063 1/20 0.51
BLM P54132 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
ALOX15 P16050 2/20 0.44
TTR P02766 1/20 0.44
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
GFER P55789 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27756784 1.00 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL8870809 0.84 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL2034753 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL31714043 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL5526027 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL3059385 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL2029800 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL2034755 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL5490059 0.83 ALDH1A1 (0.76) ALDH1A1KDM4EMAPTHSD17B10S1PR3
SCHEMBL3832263 0.83 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTHSD17B10S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9420790-B2 Molecules that induce disease resistance and improve growth in plants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-08-23 US disclosed
US-9420790-B2 Molecules that induce disease resistance and improve growth in plants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-08-23 US disclosed
US-20150289511-A1 MOLECULES THAT INDUCE DISEASE RESISTANCE AND IMPROVE GROWTH IN PLANTS UNIV CALIFORNIA (US) 2015-10-15 US disclosed
US-20150289511-A1 MOLECULES THAT INDUCE DISEASE RESISTANCE AND IMPROVE GROWTH IN PLANTS UNIV CALIFORNIA (US) 2015-10-15 US disclosed
US-9023759-B2 Molecules that induce disease resistance and improve growth in plants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-05-05 US disclosed
US-9023759-B2 Molecules that induce disease resistance and improve growth in plants THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2015-05-05 US disclosed
US-20140274700-A1 MOLECULES THAT INDUCE DISEASE RESISTANCE AND IMPROVE GROWTH IN PLANTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 US disclosed
US-20140274700-A1 MOLECULES THAT INDUCE DISEASE RESISTANCE AND IMPROVE GROWTH IN PLANTS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150289511-A1 MOLECULES THAT INDUCE DISEASE RESISTANCE AND IMPROVE GROWTH IN PLANTS IFNG, BROX, STING1 ALDH1A1 4451/4885KDM4E 3915/4885MAPT 3837/4885
US-20140274700-A1 MOLECULES THAT INDUCE DISEASE RESISTANCE AND IMPROVE GROWTH IN PLANTS IFNG, BROX, STING1 ALDH1A1 4451/4885KDM4E 3915/4885MAPT 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.